Groundbreaking Leap for Diverse Clinical Trials
The FDA’s new guidelines on participant diversity in clinical trials mark a major victory for inclusivity and scientific accuracy. This crucial step focuses on three key areas: Demolishing entry barriers, designing inclusively, and revolutionizing recruitment.
Groundbreaking Leap for Diverse Clinical Trials Read More »